Ki-ras Mutation in Lung Cancer
Author Information
Author(s): T Urban, S Ricci, R Lacave, M Antoine, M Kambouchner, F Capron, J-F Bernaudin
Primary Institution: Hopital Saint-Antoine, Hopital Tenon, Hopital Avicenne, Hopital BeNclre
Hypothesis
Are there widespread target cells containing Ki-ras mutations in bronchopulmonary carcinogenesis?
Conclusion
Ki-ras mutations were not found in non-neoplastic bronchial or lung tissues of patients with lung cancer.
Supporting Evidence
- Ki-ras mutations were detected in 20% of adenocarcinomas but not in squamous or adenosquamous carcinomas.
- No mutations were found in non-neoplastic bronchial or parenchymal samples.
- The enriched PCR-RFLP method detected mutations in 23% of adenocarcinomas.
Takeaway
The study looked for a specific mutation in lung cancer patients but found it only in cancerous tissues, not in healthy ones.
Methodology
Tissue samples from patients were analyzed using PCR and RFLP methods to detect Ki-ras mutations.
Limitations
The study focused only on specific types of lung cancer and may not represent all cases.
Participant Demographics
Patients were smokers or ex-smokers undergoing thoracotomy.
Want to read the original?
Access the complete publication on the publisher's website